-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MidphsvaPcGMwre0zgOjwFJEMdO59VQr+P8A/TYTuJQiBG+i1gD137Ljw4h9TwwC ATKpYdeF3RJhi0EDtg031g== 0001181431-09-054244.txt : 20091201 0001181431-09-054244.hdr.sgml : 20091201 20091201161958 ACCESSION NUMBER: 0001181431-09-054244 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091127 FILED AS OF DATE: 20091201 DATE AS OF CHANGE: 20091201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INHIBITEX, INC. CENTRAL INDEX KEY: 0001274913 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 742708737 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9005 WESTSIDE PARKWAY CITY: ALPHARETTA STATE: GA ZIP: 30004 BUSINESS PHONE: 678-746-1100 MAIL ADDRESS: STREET 1: 9005 WESTSIDE PARKWAY CITY: ALPHARETTA STATE: GA ZIP: 30004 FORMER COMPANY: FORMER CONFORMED NAME: INHIBITEX INC DATE OF NAME CHANGE: 20031231 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: QVT Fund LP CENTRAL INDEX KEY: 0001290165 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50772 FILM NUMBER: 091215074 BUSINESS ADDRESS: STREET 1: WALKERS SPV, WALKERS HOUSE STREET 2: P.O. BOX 908GT, MARY STREET CITY: GEORGE TOWN STATE: E9 ZIP: 00000 BUSINESS PHONE: 212-705-8800 MAIL ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: QVT Associates GP LLC CENTRAL INDEX KEY: 0001290166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50772 FILM NUMBER: 091215075 BUSINESS ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-705-8800 MAIL ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 rrd258538.xml FORM 4 X0303 4 2009-11-27 0 0001274913 INHIBITEX, INC. INHX 0001290166 QVT Associates GP LLC 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036 0 0 1 0 0001290165 QVT Fund LP WALKERS SPV, WALKERS HOUSE 87 MARY STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-9002 CAYMAN ISLANDS 0 0 1 0 Common Stock, $0.001 par value 2009-11-27 4 P 0 2000 0.96 A 8826953 I Through QVT Fund LP and Quintessence Fund L.P. Common Stock, $0.001 par value 2009-11-27 4 P 0 12300 0.96 A 8839253 I Through QVT Fund LP and Quintessence Fund L.P. Common Stock, $0.001 par value 2009-11-30 4 P 0 50000 0.99 A 8889253 I Through QVT Fund LP and Quintessence Fund L.P. On November 27, 2009, QVT Fund LP purchased an aggregate amount of 12,963 shares of Common Stock and Quintessence Fund L.P. purchased an aggregate amount of 1,337 shares of Common Stock. On November 30, 2009, QVT Fund LP purchased 45,325 shares of Common Stock and Quintessence Fund L.P. purchased 4,675 shares of Common Stock. As a result, QVT Fund LP directly beneficially owns 8,029,401 shares of Common Stock and Quintessence Fund L.P. directly beneficially owns 859,852 shares of Common Stock. QVT Associates GP LLC, as General Partner of QVT Fund LP and Quintessence Fund L.P., may be deemed to beneficially own the aggregate number of shares of Common Stock owned by QVT Fund LP and Quintessence Fund L.P. and accordingly, QVT Associates GP LLC may be deemed to be the indirect beneficial owner of an aggregate amount of 8,889,253 shares of Common Stock. The foregoing does not include the Warrants disclosed on the Form 3 filed by the reporting persons on October 30, 2009. Each of the reporting p ersons disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. /s/ Tracy Fu, Managing Member 2009-12-01 -----END PRIVACY-ENHANCED MESSAGE-----